This is feed that updates daily with CME offerings from JAMA, American College of Surgeons, and UC CMEs. Please follow the links for each to learn more.

Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?

HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA Oncology Read More

Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?

HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA OncologyRead More

Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?

HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA Oncology Read More

2020 New York Chapter Annual Meeting and Educational Event

Webinar
Wednesday, November 18, 2020, 6 – 8pm

Location City: Virtual
Location Country: United States
Event Category: ACS Chapter
Contact Name: Babette Atkins
Contact Emailbgrey@nysurgeon.org
Contact Phone: (518) 598-7755
Event Websitenysurgeon.org…
More infonysurgeon.org… Read More

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMA Read More

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMARead More

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMA Read More

Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life

CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal Medicine Read More

Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life

CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal MedicineRead More

Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life

CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal Medicine Read More

US Food and Drug Administration Support for Oncology Drug Development During COVID-19

HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA Oncology Read More

US Food and Drug Administration Support for Oncology Drug Development During COVID-19

HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA OncologyRead More

US Food and Drug Administration Support for Oncology Drug Development During COVID-19

HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA Oncology Read More

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial

LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMA Read More

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial

LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMARead More

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial

LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMA Read More

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA Oncology Read More

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA OncologyRead More

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA Oncology Read More

Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia

HEMATOLOGY | 13m 59s | Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia | JAMA Oncology Read More

Newsletter

The CRCERA Newsletter comes once a month and includes a list of the latest training opportunities. Don't miss out - sign up now!

[mc4wp_form id="55"]